Proto-Oncogene Proteins c-myb
"Proto-Oncogene Proteins c-myb" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cellular DNA-binding proteins encoded by the myb gene (GENES, MYB). They are expressed in a wide variety of cells including thymocytes and lymphocytes, and regulate cell differentiation. Overexpression of myb is associated with autoimmune diseases and malignancies.
| Descriptor ID |
D020598
|
| MeSH Number(s) |
D12.776.260.675 D12.776.624.664.700.188 D12.776.930.725
|
| Concept/Terms |
Proto-Oncogene Proteins c-myb- Proto-Oncogene Proteins c-myb
- Proto Oncogene Proteins c myb
- c-myb, Proto-Oncogene Proteins
- Proto-Oncogene Protein myb
- Proto Oncogene Protein myb
- myb, Proto-Oncogene Protein
- myb Proto-Oncogene Proteins
- Proto-Oncogene Proteins, myb
- myb Proto Oncogene Proteins
- Proto-Oncogene Products c-myb
- Proto Oncogene Products c myb
- c-myb, Proto-Oncogene Products
- Proto-Oncogene Proteins myb
- Proto Oncogene Proteins myb
- myb, Proto-Oncogene Proteins
- c-myb Protein
- c myb Protein
- c-myb Proteins
- c myb Proteins
|
Below are MeSH descriptors whose meaning is more general than "Proto-Oncogene Proteins c-myb".
Below are MeSH descriptors whose meaning is more specific than "Proto-Oncogene Proteins c-myb".
This graph shows the total number of publications written about "Proto-Oncogene Proteins c-myb" by people in this website by year, and whether "Proto-Oncogene Proteins c-myb" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proto-Oncogene Proteins c-myb" by people in Profiles.
-
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course. Acta Neuropathol. 2020 01; 139(1):193-209.
-
Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3? and CDK1. Cancer Res. 2011 Aug 01; 71(15):5265-75.
-
miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood. 2009 Sep 03; 114(10):2181-92.
-
Study of protein splicing and intein-mediated peptide bond cleavage under high-cell-density conditions. Biotechnol Prog. 2003 May-Jun; 19(3):1085-90.
-
Opposing actions of c-ets/PU.1 and c-myb protooncogene products in regulating the macrophage-specific promoters of the human and mouse colony-stimulating factor-1 receptor (c-fms) genes. J Exp Med. 1994 Dec 01; 180(6):2309-19.
-
Expression of the c-myb proto-oncogene in bovine vascular smooth muscle cells. J Biol Chem. 1992 Mar 05; 267(7):4625-30.
-
Molecular analysis of the ets genes and their products. Crit Rev Oncog. 1990; 1(4):409-36.
-
Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. J Biol Chem. 1989 Apr 25; 264(12):6990-5.